1. Home
  2. ANDE vs PHVS Comparison

ANDE vs PHVS Comparison

Compare ANDE & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Andersons Inc. (The)

ANDE

Andersons Inc. (The)

N/A

Current Price

$64.15

Market Cap

2.2B

Sector

Industrials

ML Signal

N/A

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

N/A

Current Price

$33.50

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANDE
PHVS
Founded
1947
2015
Country
United States
Switzerland
Employees
2137
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.4B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
ANDE
PHVS
Price
$64.15
$33.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
14
Target Price
★ $86.67
$57.68
AVG Volume (30 Days)
286.3K
★ 594.3K
Earning Date
11-03-2026
11-11-2026
Dividend Yield
★ 1.28%
N/A
EPS Growth
N/A
N/A
EPS
★ 2.62
N/A
Revenue
★ $11,008,928,000.00
N/A
Revenue This Year
$5.59
N/A
Revenue Next Year
$2.75
N/A
P/E Ratio
$23.88
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$44.87
$21.02
52 Week High
$82.11
$43.25

Technical Indicators

Market Signals
Indicator
ANDE
PHVS
Relative Strength Index (RSI) 43.34 59.56
Support Level N/A $33.41
Resistance Level $68.83 $36.36
Average True Range (ATR) 2.03 1.27
MACD -0.11 0.57
Stochastic Oscillator 31.54 93.53

Price Performance

Historical Comparison
ANDE
PHVS

About ANDE Andersons Inc. (The)

Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.

Share on Social Networks: